Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription 08.06.2026 2 AJNR Am J Neuroradiol 2 Ann Nucl Med 1 Brain 3 J Cereb Blood Flow Metab 4 J Nucl Cardiol 14 J Nucl Med 3 Nucl Med Commun 1 Nuklearmedizin 1 Phys Med Biol 2 PLoS One 3 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. SONI N, Ora M, Cai Y, Mark IT, et al
   A potential Adjunctive Role of 7T MRI and Amino-Acid PET in Localizing MRI-Occult Functional Pituitary Microadenomas: A Scoping Review.
   AJNR Am J Neuroradiol. 2026 Jun 4:ajnr.A9448. doi: 10.3174/ajnr.A9448.
   PubMed         Abstract available
   
   
2. LUAN H, Chen Z, Han X, Wang P, et al
   Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on (18)F-FDG-PET.
   AJNR Am J Neuroradiol. 2026;47:1664-1671.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

3. CUI Y, Wang M, Liu Y, Liu Y, et al
   Local aggressiveness and prognostic prediction in desmoid-type fibromatosis: insights from (18)F-FDG PET/CT.
   Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02221.
   PubMed         Abstract available
   
   
4. TSUSHIMA F, Koshiishi T, Shintaku T, Maruyama S, et al
   Utility of preoperative [(1)(8)F]FDG PET/CT for CT-guided biopsy polanning of large tumors: target adjustment and malignant yield with hotspot targeting.
   Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02242.
   PubMed         Abstract available
   
   

   
   Brain

5. LI LL, Wang RZ, Wang Z, Hu H, et al
   Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.
   Brain. 2025 Nov 11:awaf427. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Cereb Blood Flow Metab

6. HAHN A, Falb P, Murgas M, Klug S, et al
   EXPRESS: 18F]FDG functional PET revisited: a new perspective on the temporal dynamics of brain glucose metabolism.
   J Cereb Blood Flow Metab. 2026 Jun 1:271678X261455750.
   PubMed         Abstract available
   
   
7. EGGER K, Bozsak R, Aicher HDD, Sari H, et al
   EXPRESS: Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: A randomised [(18)F]FDG-PET Study.
   J Cereb Blood Flow Metab. 2026 Jun 1:271678X261454172.
   PubMed         Abstract available
   
   
8. CHUNG KJ, Jones T, Abdelhafez YG, Spencer BA, et al
   EXPRESS: Single-tracer [(18)F]FDG PET quantification of blood-brain barrier permeability and cerebral blood flow: Validation using dual-tracer PET.
   J Cereb Blood Flow Metab. 2026 May 31:271678X261458293.
   PubMed         Abstract available
   
   

   
   J Nucl Cardiol

9. KOUNGA C, Huck D, Sun A, Perillo A, et al
   Association of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronary microvascular dysfunction: A pilot study.
   J Nucl Cardiol. 2026;59:102675.
   PubMed         Abstract available
   
   
10. LIMA BB, Dupont WD, Carr CM, Jahangir E, et al
    Effect of deep learning attenuation correction on accuracy of stress myocardial perfusion imaging.
    J Nucl Cardiol. 2026;59:102706.
    PubMed         Abstract available
    
    
11. ALWAN M, Al-Mallah MH, Al Rifai M
    Normal is not one size fits all: Age- and sex-specific reference values for myocardial blood flow and flow reserve with rubidium-82 positron emission tomogram.
    J Nucl Cardiol. 2026;59:102729.
    PubMed        
    
    
12. NAKAMURA T, Tahara N, Koga Y, Yamagata Y, et al
    Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study.
    J Nucl Cardiol. 2026 Jun 3:102770. doi: 10.1016/j.nuclcard.2026.102770.
    PubMed         Abstract available
    
    

    
    J Nucl Med

13. VOLTIN CA, Flossdorf S, Kurch L, Winkelmann M, et al
    Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.
    J Nucl Med. 2026;67:871-877.
    PubMed         Abstract available
    
    
14. LI EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, et al
    Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 19:jnumed.125.271476. doi: 10.2967/jnumed.125.271476.
    PubMed         Abstract available
    
    
15. LOLATTE K, Hess A, Willmann M, Strunk M, et al
    Deciphering Leukocyte Subpopulation Contributions to Ventricle Remodeling and Neuroinflammation After Myocardial Infarction Using Total-Body Molecular Imaging.
    J Nucl Med. 2026 Mar 19:jnumed.125.271451. doi: 10.2967/jnumed.125.271451.
    PubMed         Abstract available
    
    
16. HUBALEWSKA-DYDEJCZYK A, Decristoforo C, Mikolajczak R, Kolenc P, et al
    Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a (99m)Tc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical Tria
    J Nucl Med. 2026;67:895-902.
    PubMed         Abstract available
    
    
17. NEISHABOURI A, Ghim M, Varli O, Ahmad AA, et al
    Molecular Imaging of Collagen Turnover in Myocardial Infarction.
    J Nucl Med. 2026 Mar 26:jnumed.125.271721. doi: 10.2967/jnumed.125.271721.
    PubMed         Abstract available
    
    
18. GIARRATANA AO, Jonaitis E, Przybelski RJ, Cody K, et al
    Longitudinal Evaluation of (18)F-MK-6240 Along the Alzheimer Disease Continuum.
    J Nucl Med. 2026;67:981-987.
    PubMed         Abstract available
    
    
19. BRENDEL M, Barthel H, Hoglinger GU
    Biologic Definition of Parkinson Disease: A Pivotal Role for Molecular Imaging.
    J Nucl Med. 2026;67:833-840.
    PubMed         Abstract available
    
    
20. URBAIN JC
    Nuclear Medicine in an Era of Exponential Growth.
    J Nucl Med. 2026;67:11A-12A.
    PubMed        
    
    
21. BAUM RP, Zhao T, Jakobsson V, Greifenstein L, et al
    Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using (177)Lu-, (90)Y-, and (225)Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.
    J Nucl Med. 2026;67:910-920.
    PubMed         Abstract available
    
    
22. KANG HG, Tashima H, Wakizaka H, Minamihisamatsu T, et al
    Sub-0.5-mm Resolution PET Versus Autoradiography: Comparison of mGluR1 Concentrations in Mouse Brain.
    J Nucl Med. 2026 Jun 4:jnumed.125.271600. doi: 10.2967/jnumed.125.271600.
    PubMed         Abstract available
    
    
23. SCHINDLER P, Brandt J, Bobe S, Krahling T, et al
    Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.
    J Nucl Med. 2026 Jun 4:jnumed.125.271376. doi: 10.2967/jnumed.125.271376.
    PubMed         Abstract available
    
    
24. JIA KY, Kuten J, Jia HY, Bent EH, et al
    Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing (68)Ga-PSMA PET/CT.
    J Nucl Med. 2026 Jun 4:jnumed.126.272009. doi: 10.2967/jnumed.126.272009.
    PubMed         Abstract available
    
    
25. MAZZIOTTA J, Czernin J
    From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an Evolving Career and Its Origins in Nuclear Medicine.
    J Nucl Med. 2026 Jun 4:jnumed.126.273012. doi: 10.2967/jnumed.126.273012.
    PubMed        
    
    
26. PAULE A, Masson S, Rose Dite Modestine J, Kara N, et al
    Role of (18)F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy.
    J Nucl Med. 2026 Jun 4:jnumed.126.272126. doi: 10.2967/jnumed.126.272126.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

27. YUE Y, Yu W, Jiang D, Tian Y, et al
    Cerebral metabolism mediates cognitive impairment in stroke-free atrial fibrillation patients: a mediation analysis using 18F-fluorodeoxyglucose PET/computed tomography.
    Nucl Med Commun. 2026 Jun 2. doi: 10.1097/MNM.0000000000002185.
    PubMed         Abstract available
    
    
28. KIM JY, Kim D, Kim GH, Yoon HJ, et al
    Effects of apolipoprotein E epsilon4 on amyloid deposition and relative cerebral perfusion in cognitively normal individuals: a dual-phase 18F-florbetaben PET study.
    Nucl Med Commun. 2026 Jun 2. doi: 10.1097/MNM.0000000000002186.
    PubMed         Abstract available
    
    
29. DONG Q, Zhou Q, Liu Y, Wang Q, et al
    Grading and detecting gastroenteropancreatic neuroendocrine neoplasms with dual-tracer ( 18 F-AlF-NOTA-octreotide/ 18 F-FDG) PET/CT: a metabolic parameter-based study.
    Nucl Med Commun. 2026 Jun 3. doi: 10.1097/MNM.0000000000002187.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

30. BUCHERT R, Meyer PT, Albert NL, Barthel H, et al
    German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025).
    Nuklearmedizin. 2026 Jun 2. doi: 10.1055/a-2821-9573.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

31. CHO MJ, Shim HS, Kim S, Lee JS, et al
    GPDM: generation-prior diffusion model for accelerated direct attenuation and scatter correction of whole-body 18F-FDG PET.
    Phys Med Biol. 2026 Jun 3. doi: 10.1088/1361-6560/ae7798.
    PubMed         Abstract available
    
    

    
    PLoS One

32. ASIM N, Sirshar M, Khan MZ, Ejaz S, et al
    Tensor enhanced chest cancer classification via CNN and Vision Transformer models.
    PLoS One. 2026;21:e0348863.
    PubMed         Abstract available
    
    
33. CUCURACHI N, Fioroni F, Grassi E, Panico N, et al
    Real-time detection of extravasation events of diagnostic and therapeutic radiopharmaceuticals in oncology.
    PLoS One. 2026;21:e0350116.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

34. SOVANI B, Ravindra SG, Javidan C, Dehdashti F, et al
    (18)F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.
    Semin Nucl Med. 2026 Jun 1:S0001-2998(26)00113.
    PubMed         Abstract available
    
    
35. SADEGHPOUR S, Saidi B, Sahafi P, Maleki F, et al
    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
    Semin Nucl Med. 2026 Jun 2:S0001-2998(26)00112.
    PubMed         Abstract available
    
    
36. AL-MALLAH MH
    The role of cardiac PET imaging in cardiac amyloidosis.
    Semin Nucl Med. 2026 May 30:S0001-2998(26)00118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum